The reimbursement decision speed for oncology new drugs in China and its determinant factors

Overview of attention for article published in Frontiers in Public Health, October 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,125 followers.

New Research: The reimbursement decision speed for oncology new drugs in China and its determinant factors: Introduction China has initiated national price negotiations to improve access to innovative drugs. Learning the… https://t.co/0lZx1D5QHp #PublicHe

31 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.